Intrauterine insemination: prognostic factors

被引:0
作者
Dias, Carla Maria Franco [1 ]
Vitorino, Gabriel Borges Tavares [1 ]
Furlan, Suelen Maria Parizotto [1 ]
Reis, Rosana Maria dos [1 ,2 ]
Silva, Ana Carolina Japur de Sa Rosa e [1 ,2 ]
Mendes, Maria Celia [1 ]
Ferriani, Rui Alberto [1 ,2 ]
Navarro, Paula Andrea [1 ,2 ]
机构
[1] Univ Sao Paulo, Dept Gynecol & Obstet, Ribeirao Preto Med Sch, Sect Human Reprod, Ribeirao Preto, Brazil
[2] CNPq, Natl Inst Hormones & Womens Hlth, Lago Sul, Brazil
来源
JORNAL BRASILEIRO DE REPRODUCAO ASSISTIDA | 2024年 / 28卷 / 02期
关键词
infertility; intrauterine insemination; prognostic; factors; clinical pregnancy rate; live birth rate; OVARIAN STIMULATION; CYCLES; PREGNANCY; SUCCESS; GONADOTROPINS; SUBFERTILITY; INFERTILITY; CLOMIPHENE; LETROZOLE; COUPLES;
D O I
10.5935/1518-0557.20240017
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To evaluate the impact of possible maternal and paternal prognostic factors and ovarian stimulation protocols on clinical pregnancy and live birth rates in intrauterine insemination (IUI) cycles. Methods: Retrospective observational study of 341 IUI cycles performed from January 2016 to November 2020 at the Assisted Reproduction Service of the Clinics Hospital of the Ribeir & atilde;o Preto Medical School, University of S & atilde;o Paulo. Clinical pregnancy and live birth rates and their potential prognostic factors were evaluated. Wilcoxon's non -parametric test was used to compare quantitative variables, and the chi-square test to compare qualitative variables, adopting a significance level of p <0.05. A logistic regression model was performed to verify which exploratory variables are predictive factors for pregnancy outcome. Results: The ovulation induction protocol using gonadotropins plus letrozole ( p =0.0097; OR 4.3286, CI 1.3040 - 14.3684) and post -capacitation progressive sperm >= 5million/mL ( p =0.0253) showed a statistically significant correlation with the live birth rate. Female and male age, etiology of infertility, obesity, multifollicular growth, endometrial thickness >= 7 mm, and time between human chorionic gonadotropin administration and IUI performance were not associated with the primary outcomes. In the group of patients with ideal characteristics (women aged< 40 years, BMI < 30 kg/m( 2) , antral follicle count >= 5, partner aged< 45 years, and post -capacitation semen with progressive spermatozoa >= 5 million/mL), the rate of clinical pregnancy was 14.8%, while that of live birth, 9.9%. Conclusions: In this study, the ovulation induction protocol with gonadotropins plus letrozole and postcapacitation progressive sperm >= 5 million/mL were the only variables that significantly correlated with intrauterine insemination success.
引用
收藏
页码:254 / 262
页数:9
相关论文
共 31 条
  • [1] Male infertility
    Agarwal, Ashok
    Baskaran, Saradha
    Parekh, Neel
    Cho, Chak-Lam
    Henkel, Ralf
    Vij, Sarah
    Arafa, Mohamed
    Selvam, Manesh Kumar Panner
    Shah, Rupin
    [J]. LANCET, 2021, 397 (10271) : 319 - 333
  • [2] Ashrafi M, 2013, INT J FERTIL STERIL, V7, P100
  • [3] Factors predictive of clinical pregnancy in the first intrauterine insemination cycle of 306 couples with favourable female patient characteristics
    Aydin, Yunus
    Hassa, Hikmet
    Oge, Tufan
    Tokgoz, Vehbi Yavuz
    [J]. HUMAN FERTILITY, 2013, 16 (04) : 286 - 290
  • [4] Intra-uterine insemination for male subfertility
    Bensdorp, A. J.
    Cohlen, B. J.
    Heineman, M. J.
    Vandekerckhove, P.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (03):
  • [5] Semen preparation techniques for intrauterine insemination
    Boomsma, Carolien M.
    Cohlen, Ben J.
    Farquhar, Cindy
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (10):
  • [6] IUI: review and systematic assessment of the evidence that supports global recommendations
    Cohlen, Ben
    Bijkerk, Aartjan
    Van der Poel, Sheryl
    Ombelet, Willem
    [J]. HUMAN REPRODUCTION UPDATE, 2018, 24 (03) : 300 - 319
  • [7] Follicle stimulating hormone versus clomiphene citrate in intrauterine insemination for unexplained subfertility: a randomized controlled trial
    Danhof, N. A.
    van Wely, M.
    Repping, S.
    Koks, C.
    Verhoeve, H. R.
    de Bruin, J. P.
    Verberg, M. F. G.
    van Hooff, M. H. A.
    Cohlen, B. J.
    van Heteren, C. F.
    Fleischer, K.
    Gianotten, J.
    van Disseldorp, J.
    Visser, J.
    Broekmans, F. J. M.
    Mol, B. W. J.
    van der Veen, F.
    Mochtar, M. H.
    [J]. HUMAN REPRODUCTION, 2018, 33 (10) : 1866 - 1874
  • [8] ART in Europe, 2014: results generated from European registries by ESHRE
    De Geyter, Ch.
    Calhaz-Jorge, C.
    Kupka, M. S.
    Wyns, C.
    Mocanu, E.
    Motrenko, T.
    Scaravelli, G.
    Smeenk, J.
    Vidakovic, S.
    Goossens, V.
    [J]. HUMAN REPRODUCTION, 2018, 33 (09) : 1586 - 1601
  • [9] Letrozole, Gonadotropin, or Clomiphene for Unexplained Infertility
    Diamond, M. P.
    Legro, R. S.
    Coutifaris, C.
    Alvero, R.
    Robinson, R. D.
    Casson, P.
    Christman, G. M.
    Ager, J.
    Huang, H.
    Hansen, K. R.
    Baker, V.
    Usadi, R.
    Seungdamrong, A.
    Bates, G. W.
    Rosen, R. M.
    Haisenleder, D.
    Krawetz, S. A.
    Barnhart, K.
    Trussell, J. C.
    Ohl, D.
    Jin, Y.
    Santoro, N.
    Eisenberg, E.
    Zhang, H.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (13) : 1230 - 1240
  • [10] Dilbaz B, 2011, Gynecol Obstet Reprod Med, V17, P28